Skip to main content
. 2016 Apr 25;7:11433. doi: 10.1038/ncomms11433

Table 1. PheWAS phenotypes associated with SNP variation in the HLA region*.

PheWAS disease Genetic liability (s.e.) P-value Class I Class II Other HLA
Known associations
 Ankylosing spondylitis 0.074 (0.013) <1.0 × 10−20 0.0006§ 1 0.012
 Type I diabetes 0.099 (0.014) <1.0 × 10−20 1 0.00002§ 0.0033§
 Rheumatoid arthritis 0.035 (0.008) <1.0 × 10−20 1§ 0.005§ 0.041§
 Multiple sclerosis 0.023 (0.006) <1.0 × 10−20 0.68§ 0.01§ 0.23§
 Hypothyroidism 0.009 (0.003) 5.6 × 10−9 0.7§ 0.067 0.13§
 Psoriasis 0.017 (0.005) 6.5 × 10−9 0.044§ 0.97 0.17
 Juvenile rheumatoid arthritis 0.025 (0.008) 1.1 × 10−8 0.21 0.026§ 0.42
 Primary biliary cirrhosis 0.017 (0.006) 6.7 × 10−8 0.41 0.057§ 0.19
 Coeliac disease 0.008 (0.004) 3.8 × 10−7 1 0.062§ 0.31
 Macular degeneration 0.013 (0.005) 3.2 × 10−5 1 1 0.014§
 Ulcerative colitis|| 0.007 (0.003) 3.9 × 10−5 n/a n/a§ n/a§
 Systemic lupus erythematosus 0.005 (0.003) 2.7 × 10−4 0.89 0.59§ 0.22§
 Premature menopause 0.006 (0.003) 1.0 × 10−3 0.72 0.72 0.25§
           
Novel associations
 Sicca syndrome 0.009 (0.004) 1.8 × 10−6 1 0.14 0.28
 Dermatomyositis and polymyositis 0.008 (0.004) 1.1 × 10−5 0.11 0.88 0.61
 Polymyalgia rheumatica 0.010 (0.005) 3.5 × 10−4 1 0.8 0.042
 Cholangitis 0.006 (0.004) 5.8 × 10−4 0.38 1 0.17
 Dermatophytosis of the body 0.004 (0.003) 6.8 × 10−4 1 1 0.16

*Only phenotypes with an FDR q<0.05 and that mapped to the GWAS Catalog or have unreported associations are shown.

From a multivariable GLMM analysis that incorporated a HLA and non-HLA GRM and adjusted for age and sex each of the PheWAS phenotypes. P-values correspond to the HLA variance component.

Shown are P-values from a multivariable GLMM analysis incorporating GRMs comprising SNPs within the specificied HLA region (see Methods).

||An estimate could not be obtained because the statistical model did not converge.

§A SNP association with a P-value<5 × 10−8 in the GWAS Catalog reported in the specified region.